COMPUGROUP MEDSPADR (Germany) Probability of Future Stock Price Finishing Under 26.85
| COPA Stock | EUR 20.80 0.20 0.97% |
COMPUGROUP |
COMPUGROUP MEDSPADR Target Price Odds to finish below 26.85
The tendency of COMPUGROUP Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under € 26.85 after 90 days |
| 20.80 | 90 days | 26.85 | close to 99 |
Based on a normal probability distribution, the odds of COMPUGROUP MEDSPADR to stay under € 26.85 after 90 days from now is close to 99 (This COMPUGROUP MEDSPADR 1 probability density function shows the probability of COMPUGROUP Stock to fall within a particular range of prices over 90 days) . Probability of COMPUGROUP MEDSPADR price to stay between its current price of € 20.80 and € 26.85 at the end of the 90-day period is about 1.74 .
Assuming the 90 days trading horizon COMPUGROUP MEDSPADR has a beta of 0.11 suggesting as returns on the market go up, COMPUGROUP MEDSPADR average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding COMPUGROUP MEDSPADR 1 will be expected to be much smaller as well. Additionally COMPUGROUP MEDSPADR 1 has an alpha of 0.8568, implying that it can generate a 0.86 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). COMPUGROUP MEDSPADR Price Density |
| Price |
Predictive Modules for COMPUGROUP MEDSPADR
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as COMPUGROUP MEDSPADR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.COMPUGROUP MEDSPADR Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. COMPUGROUP MEDSPADR is not an exception. The market had few large corrections towards the COMPUGROUP MEDSPADR's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold COMPUGROUP MEDSPADR 1, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of COMPUGROUP MEDSPADR within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.86 | |
β | Beta against Dow Jones | 0.11 | |
σ | Overall volatility | 2.78 | |
Ir | Information ratio | 0.12 |
COMPUGROUP MEDSPADR Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of COMPUGROUP MEDSPADR for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for COMPUGROUP MEDSPADR can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| COMPUGROUP MEDSPADR is way too risky over 90 days horizon | |
| COMPUGROUP MEDSPADR appears to be risky and price may revert if volatility continues | |
| COMPUGROUP MEDSPADR 1 has accumulated 685.04 M in total debt with debt to equity ratio (D/E) of 1.19, which is about average as compared to similar companies. COMPUGROUP MEDSPADR has a current ratio of 0.89, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist COMPUGROUP MEDSPADR until it has trouble settling it off, either with new capital or with free cash flow. So, COMPUGROUP MEDSPADR's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like COMPUGROUP MEDSPADR sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for COMPUGROUP to invest in growth at high rates of return. When we think about COMPUGROUP MEDSPADR's use of debt, we should always consider it together with cash and equity. |
COMPUGROUP MEDSPADR Technical Analysis
COMPUGROUP MEDSPADR's future price can be derived by breaking down and analyzing its technical indicators over time. COMPUGROUP Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of COMPUGROUP MEDSPADR 1. In general, you should focus on analyzing COMPUGROUP Stock price patterns and their correlations with different microeconomic environments and drivers.
COMPUGROUP MEDSPADR Predictive Forecast Models
COMPUGROUP MEDSPADR's time-series forecasting models is one of many COMPUGROUP MEDSPADR's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary COMPUGROUP MEDSPADR's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about COMPUGROUP MEDSPADR
Checking the ongoing alerts about COMPUGROUP MEDSPADR for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for COMPUGROUP MEDSPADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| COMPUGROUP MEDSPADR is way too risky over 90 days horizon | |
| COMPUGROUP MEDSPADR appears to be risky and price may revert if volatility continues | |
| COMPUGROUP MEDSPADR 1 has accumulated 685.04 M in total debt with debt to equity ratio (D/E) of 1.19, which is about average as compared to similar companies. COMPUGROUP MEDSPADR has a current ratio of 0.89, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist COMPUGROUP MEDSPADR until it has trouble settling it off, either with new capital or with free cash flow. So, COMPUGROUP MEDSPADR's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like COMPUGROUP MEDSPADR sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for COMPUGROUP to invest in growth at high rates of return. When we think about COMPUGROUP MEDSPADR's use of debt, we should always consider it together with cash and equity. |
Other Information on Investing in COMPUGROUP Stock
COMPUGROUP MEDSPADR financial ratios help investors to determine whether COMPUGROUP Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in COMPUGROUP with respect to the benefits of owning COMPUGROUP MEDSPADR security.